Johns Hopkins University
Shenderov Lab
The Shenderov Lab focuses on the elucidation of the mechanisms of immune resistance and response to immunotherapy in Prostate Cancer. This has led to clinical and basic research investigating the presumptive checkpoint inhibitor B7-H3.
In pursuit of understanding biomarkers and regulatory molecules of immune response, we utilize artificial intelligence, immunogenomics, spatial proteomics, transcriptomics, and clinical trial correlative samples.
We are utilizing this knowledge to engineer new immunotherapeutics with the aim to cure the incurable.
Meet The Team
Lab Alumni Family
News
Oncology Fellowship Match
December 15th , 2025
Dr. Jeffrey Schneider Matches to Oncology Fellowship at Johns Hopkins. Congratulations!
News Archive
Award to Tommy Wu
July , 2025
Tommy Wu received a Johns Hopkins Undergraduate Summer Research PURA 2025 award.
Promising Immunotherapy to Treat Localized High-Risk Prostate Cancer
February , 2024
For men with localized high-risk prostate cancer the HEAT trial is active across multiple locations in the United States and investigating if a promising immunotherapy can increase the cure rate of surgery and prevent cancer recurrence.
https://clinicaltrials.gov/study/NCT06014255
Dr. Ling Huang Matches to Oncology Fellowship
November 30, 2022
Dr. Huang is heading to Wash. U. in St. Louis! Congratulations!
Publications
Donation
It takes a team, including you, to advance cancer research!
All philanthropy supporting the Shenderov Lab is tax-deductible.
Online Donations:
Please visit our secure online giving page and indicate that
your gift is to support the Eugene Shenderov Lab.
Mail Donations:
Please make your check out to ‘Johns Hopkins University’ and mail to:
Johns Hopkins Kimmel Cancer CenterDevelopment Office
750 East Pratt Street, 17th Floor
Baltimore, MD 21202
If you would like more information about philanthropic giving,
please call the Development Office at410-361-6391.